Post by
Vega1357 on Sep 23, 2020 12:41pm
Morgan Stanley lowers price target for AQN to $15.50 US.
Somehow I missed this earlier, but Marketbeat is reporting that Morgan Stanley reduced their price target for AQN last week from $16.00 US to $15.50.
Comment by
itwillbeoknowok on Sep 23, 2020 12:55pm
This post has been removed in accordance with Community Policy
Comment by
Vega1357 on Sep 23, 2020 1:22pm
It's not my fault. Marketbeat was supposed to give me an alert for any news on AQN, but I didn't get an alert for that item. That puts the blame squarely on Marketbeat and it means that I remain the world's smartest person :)
Comment by
itwillbeoknowok on Sep 23, 2020 1:41pm
This post has been removed in accordance with Community Policy
Comment by
Vega1357 on Sep 23, 2020 1:58pm
itdwillbeoknowok, For me you have always been in the insignificant (not insugnificant) category. Learn to spell.
Comment by
masfortuna on Sep 23, 2020 4:34pm
Vega be nice please ... and it should read " Learn "how' to spell" for it to be correct. mas
Comment by
Vega1357 on Sep 24, 2020 8:47am
Nice attempt to try to distract from the fact that two major investment houses in the U.S. have reduced their target price for AQN.
Comment by
Vega1357 on Sep 24, 2020 8:57am
And while AQN had its price target lowered by some houses, ALA had its price target increased by Cannacord Genuity from $20 to $21.
Comment by
Vega1357 on Sep 27, 2020 12:47pm
One more thing, regarding your comment #6. I don't think I'm smarter than the average analyst, so their target's work fine for me.
Comment by
Vega1357 on Sep 28, 2020 8:41am
Right. The analysts are idiots and you are brilliant. Yea sure.